Novel micelle formulations to increase cutaneous bioavailability of azole antifungals.


Efficient topical drug administration for the treatment of superficial fungal infections would deliver the therapeutic agent to the target compartment and reduce the risk of systemic side effects. However, the physicochemical properties of the commonly used azole antifungals make their formulation a considerable challenge. The objective of the present… (More)
DOI: 10.1016/j.jconrel.2011.03.003


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.